Arkansas researchers are testing a product commonly used to treat ticks and fleas on pets to target fly and mosquito larvae ...

In the U.S., wastewater surveillance for public health became vital during the COVID-19 pandemic, when the U.S. Centers for Disease Control and ...

Marcel Imwinkelried, Chief Executive Officer Siegfried: “Aligned with Siegfried's strategy EVOLVE+, the new lab facility marks a key milestone in DINAMIQS' journey to becoming the leading CDMO in the ...

NGN-401 uses an adeno-associated virus serotype 9 vector to deliver a full-length functional MECP2 ... and has received regenerative medicine advanced therapy, orphan drug, fast-track, and rare ...

A 36-year-old man from Jorabagan died from dengue virus at RG Kar Medical College Hospital, marking the first dengue death in ...

Punjab's Health Minister announced plans to recruit 400 doctors to enhance healthcare services and combat dengue, along with ...

Assistant Professor of East Asian Religions Andrew Macomber presented a talk Oct. 23 at the 2024 Zombie Apocalypse Medicine ...

RP-L102, which the firm designed to treat a form of disease caused by FANCA mutations, is already under review with the European Medicines Agency.

Steve Favaloro, Chairman and CEO, said, "I am thrilled to welcome Pam and Stuart to our board at an exciting time in Genezen's development. They bring a wealth of manufacturing, drug development, and ...

The gene therapy improved annualized bleed rates, though a handful of study participants resumed factor IX prophylaxis.